Aberrant dopamine transmission and cognitive dysfunction in animal models of Parkinson's disease

Journal of Parkinson's Disease

Volumn 1, Issue 2, 2011, Pages 151-165

  Lelos, M J ^a   Dunnett, S B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

6 hydroxydopamine; animal model; cognition; executive control; neuropsychiatric symptoms; operant tests; Parkinson's disease; rat

Indexed keywords

DOPAMINE; OXIDOPAMINE;

ANIMAL BEHAVIOR; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE MODEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; EXECUTIVE FUNCTION; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; HUMAN; INSTRUMENTAL CONDITIONING; LEARNING STYLE; MENTAL FUNCTION; MOLECULAR PATHOLOGY; MOTOR PERFORMANCE; NEUROPSYCHIATRY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REACTION TIME; RESPONSE TIME; REVIEW; RODENT; SELECTIVE ATTENTION; STATE DEPENDENT LEARNING; WORKING MEMORY;

ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE; PARKINSON DISEASE; RECEPTORS, DOPAMINE;

EID: 80054849224     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-2011-11036     Document Type: Review

References (113)

1. Owen AM, Iddon JL, Hodges JR, Summers BA & Robbins TW (1997) Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia, 35, 519-532. (Pubitemid 27144004)
2. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA & Emre M (2010) Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology, 75, 1062-1069.
3. Lewis SJ, Slabosz A, Robbins TW, Barker RA & OwenAM (2005) Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia, 43, 823-832. (Pubitemid 40248892)
4. Dias FM, Kummer A, Doyle FC, Harsanyi E, Cardoso F, Fontenelle LF & Teixeira AL (2011) Psychiatric disorders in primary focal dystonia and in Parkinson's disease. NeuropsychiatrDis Treat, 7, 111-116.
5. Aarsland D, Bronnick K, Alves G, Tysnes OB, Pedersen KF, Ehrt U & Larsen JP (2009) The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry, 80, 928-930.
6. Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R & Wittchen HU (2010) Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol, 257, 1073-1082.
7. Colpaert FC (1987) Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology, 26, 1431-1440. (Pubitemid 17160562)
8. De Ryck M, Schallert T & Teitelbaum P (1980) Morphine versus haloperidol catalepsy in the rat:Abehavioral analysis of postural support mechanisms. Brain Res, 201, 143-172. (Pubitemid 10015156)
9. Uretsky NJ & Iversen LL (1969) Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature, 221, 557-559.
10. Breese GR & Traylor TD (1971) Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br J Pharmacol, 42, 88-99.
11. Ungerstedt U (1971) Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl, 367, 95-122.
12. Zigmond MJ & Stricker EM (1972) Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science, 177, 1211-1214.
13. Zigmond MJ&StrickerEM(1973) Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science, 182, 717-720.
14. Pierucci M, Di Matteo V, Benigno A, Crescimanno G, Esposito E & Di Giovanni G (2009) The unilateral nigral lesion induces dramatic bilateral modification on rat brain monoamine neurochemistry. Ann N Y Acad Sci, 1155, 316-323.
15. UngerstedtU&ArbuthnottGW(1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res, 24, 485-493.
16. Ungerstedt U (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl, 367, 49-68.
17. Ferro MM, Bellissimo MI, Anselmo-Franci JA, Angellucci ME, Canteras NS & Da Cunha C (2005) Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: Histological, neurochemical, motor and memory alterations. J Neurosci Methods, 148, 78-87. (Pubitemid 41423461)
18. Sirinathsinghji DJ, Heavens RP, Richards SJ, Beresford IJ & Hall MD (1988) Experimental hemiParkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway-I. Behavioural, neurochemical and histological characterization of the lesion. Neuroscience, 27, 117-128.
19. Kitt CA, Cork LC, Eidelberg E, Joh TH & Price DL (1987) Injury of catecholaminergic neurons after acute exposure to MPTP. Annals of the New York Academy of Sciences, 495, 730-731.
20. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP & Langston JW (2011) Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect, 119, 866-872.
21. Ren JP, Zhao YW & Sun XJ (2009) Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice. Chin Med J (Engl), 122, 2366-2371.
22. Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H & Funk RH (2010) Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. Plos One, 5, e8762.
23. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI&NussbaumRL(1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047. (Pubitemid 27443610)
24. Henchcliffe C & Beal MF(2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol, 4, 600-609.
25. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A & Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders. Science, 287, 1265-1269. (Pubitemid 30112148)
26. Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V, Zhou C, Geghman K, BogdanovM, Przedborski S, Beal MF, Burke RE & Li C (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci, 12, 826-828.
27. Kirik D & Bjorklund A (2003) Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors. Trends Neurosci, 26, 386-392. (Pubitemid 36794555)
28. Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ & Bjorklund A (2002) Parkinsonlike neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci, 22, 2780-2791. (Pubitemid 37465827)
29. Maingay M, Romero-RamosM&Kirik D (2005) Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: A new model for Parkinson's disease. CNS Spectr, 10, 235-244. (Pubitemid 40489292)
30. Williams-Gray CH, Foltynie T, Lewis SJ & Barker RA (2006) Cognitive deficits and psychosis in Parkinson's disease: A review of pathophysiology and therapeutic options. CNS Drugs, 20, 477-505. (Pubitemid 43830737)
31. Tadaiesky MT, Dombrowski PA, Figueiredo CP, Cargnin- Ferreira E, Da CunhaC&Takahashi RN (2008) Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience, 156, 830-840.
32. Vuckovic MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, Petzinger GM & Jakowec MW (2008) Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Neurobiol Dis, 32, 319-327.
33. Taylor TN, Caudle WM & Miller GW (2011) VMAT2- deficient mice display nigral and extranigral pathology and motor and nonmotor symptoms of Parkinson's disease. Parkinson's Dis, 2011, 124165.
34. Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG & Miller GW (2009) Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci, 29, 8103-8113.
35. Vernon AC (2009) Mice with reduced vesicular monoamine storage content display nonmotor features of Parkinson's disease. J Neurosci, 29, 12842-12844.
36. CanavanAG, Passingham RE, Marsden CD, Quinn N,Wyke M & Polkey CE (1989) The performance on learning tasks of patients in the early stages of Parkinson's disease. Neuropsychologia, 27, 141-156. (Pubitemid 19084932)
37. Vriezen ER & Moscovitch M (1990) Memory for temporal order and conditional associative-learning in patients with Parkinson's disease. Neuropsychologia, 28, 1283-1293.
38. Postle BR, Jonides J, Smith EE, Corkin S & Growdon JH 1997) Spatial, but not object, delayed response is impaired in early Parkinson's disease. Neuropsychology, 11, 171-179. (Pubitemid 27211805)
39. Postle BR, Locascio JJ, Corkin S & Growdon JH (1997) The time course of spatial and object learning in Parkinson's disease. Neuropsychologia, 35, 1413-1422. (Pubitemid 27455569)
40. Rafal RD, Friedman JH & Lannon MC (1989) Preparation of manual movements in hemiParkinsonism. J Neurol Neurosurg Psychiatry, 52, 399-402. (Pubitemid 19075090)
41. Choi WY, Balsam PD & Horvitz JC (2005) Extended habit training reduces dopamine mediation of appetitive response expression. J Neurosci, 25, 6729-6733. (Pubitemid 41023140)
42. Brown VJ & Robbins TW (1989) Deficits in response space following unilateral striatal dopamine depletion in the rat. J Neurosci, 9, 983-989. (Pubitemid 19085882)
43. Carli M, Jones GH & Robbins TW (1989) Effects of unilateral dorsal and ventral striatal dopamine depletion on visual neglect in the rat: A neural and behavioural analysis. Neuroscience, 29, 309-327. (Pubitemid 19113423)
44. Brown VJ & Robbins TW (1991) Simple and choice reaction time performance following unilateral striatal dopamine depletion in the rat, Impaired motor readiness but preserved response preparation. Brain, 114(Pt 1B), 513-525.
45. Baunez C, Nieoullon A&AmalricM(1995) Dopamine and complex sensorimotor integration: Further studies in a conditioned motor task in the rat. Neuroscience, 65, 375-384.
46. Dowd E & Dunnett SB (2005) Comparison of 6-hydroxydopamine- induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats. Behav Brain Res, 159, 153-161. (Pubitemid 40410597)
47. Schultz W (2001) Reward signaling by dopamine neurons. Neuroscientist, 7, 293-302. (Pubitemid 32666374)
48. Dowd E & Dunnett SB (2007) Movement without dopamine: Striatal dopamine is required to maintain but not to perform learned actions. Biochem Soc Trans, 35, 428-432. (Pubitemid 46596522)
49. de Wit S, Barker RA, Dickinson AD & Cools R (2011) Habitual versus goal-directed action control in Parkinson disease. J Cogn Neurosci, 23, 1218-1229.
50. Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR & Obeso JA (2010) Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease. Nat Rev Neurosci, 11, 760-772.
51. Dickinson A (1981) Conditioning and associative learning. Br Med Bull, 37, 165-168. (Pubitemid 11082810)
52. Colwill RM & Rescorla RA (1990) Effect of reinforcer devaluation on discriminative control of instrumental behavior. J Exp Psychol Anim Behav Process, 16, 40-47.
53. Balleine B, Ball J & Dickinson A (1994) Benzodiazepineinduced outcome revaluation and the motivational control of instrumental action in rats. Behav Neurosci, 108, 573-589. (Pubitemid 24200065)
54. Dickinson A, Balleine B, Watt A, Gonzalez F & Boakes RA (1995) Motivational control after extended instrumental training. Animal Learning & Behavior, 23, 197-206.
55. Yin HH, Ostlund SB, Knowlton BJ & Balleine BW (2005) The role of the dorsomedial striatum in instrumental conditioning. European Journal of Neuroscience, 22, 513-523. (Pubitemid 41097624)
56. Yin HH&Knowlton BJ (2006) The role of the basal ganglia in habit formation. Nat Rev Neurosci, 7, 464-476. (Pubitemid 44012286)
57. Yin HH, Knowlton BJ&BalleineBW(2004) Lesions of dorsolateral striatum preserve outcome expectancy but disrupt abit formation in instrumental learning. Eur J Neurosci, 19, 181-189. (Pubitemid 38122084)
58. Yin HH, Knowlton BJ & Balleine BW (2005) Blockade of NMDA receptors in the dorsomedial striatum prevents action-outcome learning in instrumental conditioning. Eur J Neurosci, 22, 505-512. (Pubitemid 41097623)
59. Yin HH, Knowlton BJ&BalleineBW(2006) Inactivation of dorsolateral striatum enhances sensitivity to changes in the action-outcome contingency in instrumental conditioning. Behav Brain Res, 166, 189-196. (Pubitemid 41785362)
60. PackardMG&WhiteNM(1991) Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav Neurosci, 105, 295-306.
61. Nelson A & Killcross S (2006) Amphetamine exposure enhances habit formation. J Neurosci, 26, 3805-3812.
62. Ashby FG, Turner BO & Horvitz JC (2010) Cortical and basal ganglia contributions to habit learning and automaticity. Trends Cogn Sci, 14, 208-215.
63. Costa RM (2007) Plastic corticostriatal circuits for action learning: whats dopamine got to do with it? Ann N Y Acad Sci, 1104, 172-191. (Pubitemid 47092741)
64. Wickens JR, Horvitz JC, Costa RM & Killcross S (2007) Dopaminergic mechanisms in actions and habits. J Neurosci, 27, 8181-8183. (Pubitemid 47219602)
65. Horvitz JC (2002) Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav Brain Res, 137, 65-74. (Pubitemid 35346429)
66. Jedynak JP, Uslaner JM, Esteban JA & Robinson TE (2007) Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci, 25, 847-853.
67. Faure A, Haberland U, Conde F & El Massioui N (2005) Lesion to the nigrostriatal dopamine system disrupts stimulus- response habit formation. J Neurosci, 25, 2771-2780.
68. Faure A, Leblanc-Veyrac P & El Massioui N (2010) Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism. Neuroscience, 168, 477-486.
69. Naneix F, Marchand AR, Di Scala G, Pape JR & Coutureau E (2009) A role for medial prefrontal dopaminergic innervation in instrumental conditioning. J Neurosci, 29, 6599-6606.
70. Lex B & HauberW(2010) The role of dopamine in the prelimbic cortex and the dorsomedial striatum in instrumental conditioning. Cereb Cortex, 20, 873-883.
71. Hitchcott PK, Quinn JJ & Taylor JR (2007) Bidirectional modulation of goal-directed actions by prefrontal cortical dopamine. Cereb Cortex, 17, 2820-2827. (Pubitemid 350129441)
72. Solis-Vivanco R, Ricardo-Garcell J, Rodriguez-Camacho M, Prado-Alcala RA, Rodriguez U, Rodriguez-Violante M & Rodriguez-Agudelo Y (2011) Involuntary attention impairment in early Parkinson's disease: An event-related potential study. Neurosci Lett, 495, 144-149.
73. Nys GM, Santens P&Vingerhoets G (2010) Horizontal and vertical attentional orienting in Parkinson's disease. Brain Cogn, 74, 179-185.
74. Cole BJ & Robbins TW (1989) Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res, 33, 165-179. (Pubitemid 19141065)
75. Baunez C & Robbins TW (1999) Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience, 92, 1343-1356. (Pubitemid 29292570)
76. Turle-Lorenzo N, Maurin B, Puma C, Chezaubernard C, Morain P, Baunez C, Nieoullon A & AmalricM(2006) The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: Relevance for Parkinson's disease. J Pharmacol Exp Ther, 319, 914-923.
77. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ & RobbinsTW(2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci, 20, 1208-1215. (Pubitemid 30220477)
78. Agnoli L & Carli M (2011) Synergistic interaction of dopamine D(1) and glutamate N-methyl-d-aspartate receptors in the rat dorsal striatum controls attention. Neuroscience, 185, 39-49.
79. Chudasama Y & Robbins TW (2004) Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology, 29, 1628-1636. (Pubitemid 39150104)
80. Gotham AM, Brown RG & Marsden CD (1988) 'Frontal cognitive function in patients with Parkinson's disease on and off levodopa. Brain, 111(Pt 2), 299-321.
81. Beatty WW, Staton RD, Weir WS, Monson N & Whitaker HA (1989) Cognitive disturbances in Parkinson's disease. J Geriatr Psychiatry Neurol, 2, 22-33.
82. Monchi O, Petrides M, Petre V, Worsley K & Dagher A (2001)Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci, 21, 7733-7741. (Pubitemid 32904972)
83. Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K & Dagher A (2004) Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci, 24, 702-710. (Pubitemid 38166496)
84. Birrell JM & Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci, 20, 4320-4324. (Pubitemid 30365702)
85. Oswald CJ, Yee BK, Rawlins JN, Bannerman DB, Good M & Honey RC (2001) Involvement of the entorhinal cortex in a process of attentional modulation: Evidence from a novel variant of an IDS/EDS procedure. Behav Neurosci, 115, 841-849. (Pubitemid 32738330)
86. Crofts HS, Dalley JW, Collins P, Van Denderen JC, Everitt BJ, Robbins TW & Roberts AC (2001) Differential effects of 6-OHDAlesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex, 11, 1015-1026. (Pubitemid 33021232)
87. Collins P,Wilkinson LS, Everitt BJ, RobbinsTW&Roberts AC (2000) The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. Behav Neurosci, 114, 3-17. (Pubitemid 30131582)
88. Floresco SB, Magyar O, Ghods-Sharifi S, Vexelman C & Tse MT (2006) Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology, 31, 297-309. (Pubitemid 43113395)
89. Stefani MR & Moghaddam B (2006) Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. J Neurosci, 26, 8810-8818. (Pubitemid 44319416)
90. Whishaw IQ & Dunnett SB (1985) Dopamine depletion, stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues. Behav Brain Res, 18, 11-29. (Pubitemid 16208491)
91. Sawaguchi T & Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: Involvement inworking memory. Science, 251, 947-950. (Pubitemid 21926192)
92. Beste C, Dziobek I, Hielscher H, Willemssen R & Falkenstein M (2009) Effects of stimulus-response compatibility on inhibitory processes in Parkinson's disease. Eur J Neurosci, 29, 855-860.
93. Obeso I, Wilkinson L, Casabona E, Bringas ML, Alvarez M, Alvarez L, Pavon N, Rodriguez-Oroz MC, Macias R, Obeso JA&JahanshahiM(2011) Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Exp Brain Res, 212, 371-383.
94. Henderson T, Georgiou-Karistianis N, White O, Millist L, Williams DR, Churchyard A & Fielding J (2011) Inhibitory control during smooth pursuit in Parkinson's disease and Huntingtons disease. Mov Disord. doi: 10.1002/mds.23757 [Epub ahead of print].
95. Colzato LS, van den Wildenberg WP, van Wouwe NC, Pannebakker MM & Hommel B (2009) Dopamine and inhibitory action control: Evidence from spontaneous eye blink rates. Exp Brain Res, 196, 467-474.
96. Aron AR (2007) The neural basis of inhibition in cognitive control. Neuroscientist, 13, 214-228. (Pubitemid 46801761)
97. Cools R (2008) Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist, 14, 381-395. (Pubitemid 352010072)
98. Hwang WJ, Yao WJ, Wey SP, Shen LH & Ting G (2002) Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation. Eur Neurol, 47, 113-117. (Pubitemid 34161164)
99. Antonini A, Schwarz J, Oertel WH, Pogarell O & Leenders KL (1997) Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]raclopride. Mov Disord, 12, 33-38. (Pubitemid 27032877)
100. Eagle DM, Bari A & Robbins TW (2008) The neuropsychopharmacology of action inhibition: Cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl), 199, 439-456.
101. Eagle DM, Wong JC, Allan ME, Mar AC, Theobald DE & Robbins TW (2011) Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci, 31, 7349-7356.
102. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW&RobbinsTW(2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology, 33, 1028-1037. (Pubitemid 351367544)
103. Stephan MA, Meier B, Zaugg SW, Kaelin-Lang A (2011) Motor sequence learning performance in Parkinson's disease patients depends on the stage of disease. Brain Cogn, 75, 135-140.
104. Price A & Shin JC (2009) The impact of Parkinson's disease on sequence learning: Perceptual pattern learning and executive function. Brain Cogn, 69, 252-261.
105. Levesque M, Bedard MA, Courtemanche R, Tremblay PL, Scherzer P & Blanchet PJ (2007) Raclopride-induced motor consolidation impairment in primates: Role of the dopamine type-2 receptor in movement chunking into integrated sequences. Exp Brain Res, 182, 499-508. (Pubitemid 47403851)
106. EckartMT, Huelse-Matia MC,McDonald RS&Schwarting RK (2010) 6-hydroxydopamine lesions in the rat neostriatum impair sequential learning in a serial reaction time task. Neurotox Res, 17, 287-298.
107. Tremblay PL, Bedard MA, Levesque M, Chebli M, Parent M, Courtemanche R & Blanchet PJ (2009) Motor sequence learning in primate: Role of the D2 receptor in movement chunking during consolidation. Behav Brain Res, 198, 231-239.
108. Domenger D&Schwarting RK (2008) Effects of neostriatal 6-OHDA lesion on performance in a rat sequential reaction time task. Neurosci Lett, 444, 212-216.
109. Eckart MT, Huelse-Matia MC, Loer D & Schwarting RK (2010) Acquisition and performance in a rat sequential reaction time task is not affected by subtotal ventral striatal 6-OHDA lesions. Neurosci Lett, 476, 27-31.
110. Zweig RM, Jankel WR, Hedreen JC, Mayeux R & Price DL (1989) The pedunculopontine nucleus in Parkinson's disease. Ann Neurol, 26, 41-46.
111. Ferrer I (2011) Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease. Parkinson's Dis, 2011, 708404.
112. Hasselmo ME & Sarter M (2011) Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology, 36, 52-73.
113. Kehagia AA, Murray GK & Robbins TW (2010) Learning and cognitive flexibility: Frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol, 20, 199-204.